Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$58.02 -0.34 (-0.58%)
At close: Oct 23, 2026 · 4:00 PM EDT

Arrowhead Pharmaceuticals (ARWR) Sale and Maturity of Investments (2011 - 2026)

Updated

Analysis

Arrowhead Pharmaceuticals (ARWR) Sale and Maturity of Investments (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Arrowhead Pharmaceuticals 8.19 Bn 2.97 Bn - 124.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 124.67 Mn
Dec 31, 2025 115.34 Mn
Sep 30, 2025 101.75 Mn
Jun 30, 2025 240.48 Mn
Mar 31, 2025 229.23 Mn
Dec 31, 2024 118.18 Mn
Sep 30, 2024 93.70 Mn
Jun 30, 2024 140.03 Mn
Mar 31, 2024 75.12 Mn
Dec 31, 2023 133.50 Mn
Sep 30, 2023 106.57 Mn
Jun 30, 2023 78.16 Mn
Mar 31, 2023 72.58 Mn
Dec 31, 2022 69.42 Mn
Sep 30, 2022 69.16 Mn
Jun 30, 2022 145.81 Mn
Mar 31, 2022 17.51 Mn
Dec 31, 2021 38.27 Mn
Sep 30, 2021 35.46 Mn
Jun 30, 2021 39.59 Mn
API Access

Arrowhead Pharmaceuticals Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ARWR&period=max&api_key=YOUR_API_KEY